Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IPSEY

Recent news which mentions IPSEY

Why These Two Biotech Stocks Blasted Higher This Week
Tickers ALBO AZN CINC IPSEY
Tags ALBO AZN Market News
From Motley Fool
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday
Tickers ALBO DCT IPSEY
Tags ALBO DCT Market News
From Motley Fool
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
Tickers ALBO IPSEF IPSEY
Tags News Eurasia ALBO
From Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
Tickers EXEL IPSEY RHHBY TAK
Tags Market News EXEL RHHBY
From Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
Tickers IPSEF IPSEY MACK
Tags Trading Ideas premarket trading News
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
Tickers APLS ARDX AZN FOLD
Tags SPPI VERU News
From Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
Tickers ALNY AMLX AZN BLUE
Tags SPPI RVNC News
From Benzinga
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
Tickers GNFT IPSEY
Tags Trading Ideas M&A Eurasia
From Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
Tickers IPSEF IPSEY MACK
Tags Trading Ideas News Movers
From Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Tickers AFIB AGRX AGTC AMST
Tags SRRK SHCR PETV
From Benzinga
Why Adaptimmune Therapeutics Stock Is Popping Today
Tickers ADAP EPZM IPSEY
Tags IPSEY Recent Press Releases Market News
From Motley Fool
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
Tickers AFIB AGRX AGTC ARMP
Tags EAR RGS Small Cap
From Benzinga
Why Epizyme Stock Is Soaring Today
Tickers EPZM IPSEY
Tags IPSEY Recent Press Releases Market News
From Motley Fool
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Tickers ALPMF ALPMY AXSM AZN
Tags AZN DSNKY NUVB
From Benzinga
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
Tickers EPZM IPSEF IPSEY
Tags Trading Ideas M&A News
From Benzinga
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
Tickers BMY ETSY EXEL IPSEY
Tags EXEL Market News ETSY
From Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags OCUL BLTE News
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags Health Care Market News EXEL
From Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags IPSEY Biotech General
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags News RHHBF BAYZF
From Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
Tickers ABBV GILD HAL IBM
Tags IBM PFE HAL
From Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
Tickers IPSEF IPSEY
Tags Biotech Briefs IPSEY
From Benzinga
GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters
Tickers BABA FUTU GNFT IPSEY
Tags NVAX NASDAQ:GNFT,OTCMKTS:IPSEY,NYSE:BABA,NASDAQ:NVAX,NASDAQ:FUTU Market News
From InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Tickers ABEO ADGI BLIN CERN
Tags SPRB KXIN Today's Market
From InvestorPlace
Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful
Tickers GNFT IPSEF IPSEY
Tags Trading Ideas Long Ideas News
From Benzinga
Ipsen Stock Declines After Pulling Rare Disease Application
Tickers IPSEF IPSEY
Tags News New Drug Application Trading Ideas
From Benzinga
Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders
Tickers IPSEF IPSEY XCUR
Tags News XCUR Long Ideas
From Benzinga
Ipsen Beefs Up Pre-Clinical Oncology Pipeline With Over $850M Deal With BAKX Therapeutics
Tickers IPSEF IPSEY
Tags News Benzinga General
From Benzinga
Ipsen In-Licenses Parkinson's Candidate From IRLAB
Tickers IPSEY
Tags News Contracts General
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.